Mei Xie

机构：Capital University, Capital Medical University, Beijing Shijitan Hospital · ORCID：0000-0001-9515-8115

发表论文 50 篇 · 总被引 501 次 · h-index 13

代表论文

• Mature tertiary lymphoid structures: important contributors to anti-tumor immune efficacy (2024 · Frontiers in Immunology · 被引 35)
• Diagnosis and treatment experience of Chlamydia psittaci pneumonia: A multicenter retrospective study in China (2024 · BMC Infectious Diseases · 被引 22)
• Immune‐related adverse events in non‐small cell lung cancer: Occurrence, mechanisms and therapeutic strategies (2024 · Clinical and Translational Medicine · 被引 20)
• Optimization of FFPE preparation and identification of gene attributes associated with RNA degradation (2024 · NAR Genomics and Bioinformatics · 被引 12)
• Predictive biomarkers for immune checkpoint inhibitors therapy in lung cancer (2024 · Human Vaccines & Immunotherapeutics · 被引 11)
• Tertiary lymphoid structures as potential biomarkers for cancer prediction and prognosis (2024 · International Immunopharmacology · 被引 11)